XML 70 R38.htm IDEA: XBRL DOCUMENT
v3.21.2

Corporate Organization and Company Overview (Details) |  |  | 1 Months Ended | 6 Months Ended | 7 Months Ended | 8 Months Ended
--- | --- | --- | --- | --- | --- | ---
Jun. 30, 2021 USD ($) | Mar. 26, 2021 USD ($) | Dec. 31, 2020 USD ($) shares | Jun. 30, 2021 USD ($) product shares | Jun. 30, 2021 USD ($) shares | Jun. 30, 2021 USD ($)
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |
Number of products approved by Food and Drug Administration | product |  |  |  | 5 |  |
Equity Distribution Agreement |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |
Sale of stock, aggregate offering price |  |  | $ 25,000 |  |  |
Number of shares issued in transaction (in shares) | shares |  |  | 930,993 |  |  |
Consideration received on sale of stock |  |  | $ 6,055,000 |  |  |
Payments for stock issuance costs |  |  | $ (473,000) |  |  |
At-the-Market Offering, Amendment No. 1 | Maximum |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |
Sale of stock, aggregate offering price |  | $ 50,000,000 |  |  |  |
At-the-Market Offering |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |
Number of shares issued in transaction (in shares) | shares |  |  |  | 3,977,053 | 4,907,986 |
Consideration received on sale of stock |  |  |  | $ 18,505,000 | $ 24,560,000 |
Payments for stock issuance costs |  |  |  | $ (933,000) |  | $ (1,406,000)
Remaining amount available for offering | $ 49,038,000 |  |  |  |  |

X
- Definition Number Of Products Approved By Food And Drug Administration + References No definition available. + Details
Name: | aqst_NumberOfProductsApprovedByFoodAndDrugAdministration
Namespace Prefix: | aqst_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Sale of Stock, Aggregate Offering Price + References No definition available. + Details
Name: | aqst_SaleOfStockAggregateOfferingPrice
Namespace Prefix: | aqst_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Sale Of Stock, Remaining Amount Available For Offering + References No definition available. + Details
Name: | aqst_SaleOfStockRemainingAmountAvailableForOffering
Namespace Prefix: | aqst_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow for cost incurred directly with the issuance of an equity security. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585 + Details
Name: | us-gaap_PaymentsOfStockIssuanceCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Cash received on stock transaction after deduction of issuance costs. + References No definition available. + Details
Name: | us-gaap_SaleOfStockConsiderationReceivedOnTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SubsidiarySaleOfStockLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=aqst_EquityDistributionAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=aqst_AtTheMarketOfferingAmendmentOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=aqst_AtTheMarketOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |